About IVD
IVD tests are helpful in diagnosis, screening, and disease management in humans and animals. These tests are usually performed in controlled environment, and they
include blood analysis for the sign of infection and urine for the presence of glucose. The purpose of IVD test is not only to direct therapeutic effect but also to
provide the health status of a patient. IVD plays an important role in supporting the decision making for clinical conditions. These advances have led to the
development of point of care and self-test, which are easy and convenient for patients and medical professionals to use. The self-test include pregnancy test, blood
glucose monitoring, cholesterol testing, infectious disease testing, and cardiac biomarker tests. IVD test can be performed in various settings, including clinical
laboratory, a physician’s office, or at home.
Technavio's analysts forecast the IVD market in China to grow at a CAGR of 13.47% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the IVD market in China for the period 2015–2019. The market can be divided into three segments:
consumables, instruments, and services. To calculate the market size, the report considers the revenue generated from the three segments.
Technavio's report, IVD Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the
market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Vendors
• Abbott Laboratories
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
Other Prominent Vendors
• Alere
• Atlas Link Biotech
• Autobio Diagnostics
• Bioneovan
• Bio-Rad Laboratories
• Bioptik Technology
• Boson Biotech
• C&G Biotech
• Changchun Wancheng Bio-elect
• Changsha City Epower Electronics & Science
• Cepheid
• Chongqing Haray International Business
• Cusabio Biotech
• Dako
• Fudakang Ind'l
• GE Healthcare
• Grifols
• Guangzhou Maya Medical Equipment
• Hologic
• Illumina
• Innovation Biotech
• Intec Products
• Jiaxing Smir Medical Devices
• Jiangxi Zhongchenda Industrial Investment
• Johnson & Johnson
• Luminex
• Nantong Egens Biotechnology Company
• Nantong Voyage International Trade
• PerkinElmer
• Qiagen
• Quicking Biotech
• Quest Diagnostics
• Secure Detect
• Shanghai Jiuyi International Trade
• Shanghai Outdo Biotech
• Shenzhen Fitconn Technology
• Siemens Healthcare
• Shiny Health Import & Export
• Snibe
• Sunrising Enterprise
• Wuhan HNC Technology
• Yilongyatu
• Yuan Yu Bio-Tech
• Zhejiang Orient Gene Biotech
Market Driver
• Rise in Geriatric Population
• For a full, detailed list, view our report
Market Challenge
• Challenges for International Vendors
• For a full, detailed list, view our report
Market Trend
• Change in Healthcare System
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Healthcare Structure in China
07.1 Rise in Privatization
07.2 Registration Process of Medical Devices for Global Manufacturers
08. Opportunities for Global and Local Vendors
08.1 Local Vendors
08.1.1 Challenges for Local Vendors
08.2 Global Vendors
08.2.1 Challenges for Global Vendors
09. Market Segmentation by Application
09.1 Professional Diagnostics
09.2 Diabetic Care
09.3 Molecular Diagnostics
09.4 Tissue Diagnostics
10. Market Segmentation by Component
10.1 Reagents
10.2 Instruments
10.3 Services
10.4 IVD Reagents Market in China
10.4.1 Market Size and Forecast
10.5 IVD Instruments Market in China
10.5.1 Market Size and Forecast
10.6 IVD Services Market in China
10.6.1 Market Size and Forecast
11. Market Segmentation by Technique
11.1 POC Testing
11.2 Immunoassays
11.3 Clinical Chemistry
11.4 Microbiology
11.5 Hematology
11.6 Others
12. Market Segmentation by End-user
12.1 Hospitals and Diagnostic Laboratories
12.2 Home Care
12.3 Academic and Research Institutes
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Multinational Companies
20.2.2 Domestic Enterprises
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Abbott Diagnostics
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Geographical Presence
21.1.4 SWOT Analysis
21.2 bioMeriux
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Geographical Segmentation by Revenue 2013
21.2.5 Business Strategy
21.2.6 Recent Developments
21.2.7 SWOT Analysis
21.3 Danaher
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Segmentation by Geography
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 Roche Diagnostics
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation by Revenue 2014
21.4.4 Business Segmentation by Revenue 2013 and 2014
21.4.5 Geographical Segmentation by Revenue 2014
21.4.6 Business Strategy
21.4.7 Recent Developments
21.4.8 SWOT Analysis
22. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: IVD Market in China 2014-2019 ($ millions)
Exhibit 3: Healthcare Reforms in China
Exhibit 4: Timeline of Privatization of China's Healthcare System
Exhibit 5: Segmentation of IVD Market in China by Application
Exhibit 6: Segmentation of IVD Market in China by Application 2014
Exhibit 7: Segmentation of IVD Market in China by Component
Exhibit 8: Segmentation of IVD Market in China by Component in 2014
Exhibit 9: IVD Reagents Market in China 2014-2019 ($ millions)
Exhibit 10: IVD Instruments Market in China 2014-2019 ($ millions)
Exhibit 11: IVD Services Market in China 2014-2019 ($ millions)
Exhibit 12: Segmentation of IVD Market in China by Component in 2014-2019
Exhibit 13: Segmentation of IVD Market in China by Component in 2014-2019 ($ millions)
Exhibit 14: Segmentation of IVD Market in China by Technique
Exhibit 15: Segmentation of IVD Market in China by Technique 2014
Exhibit 16: Segmentation of IVD Market in China by End-user
Exhibit 17: Segmentation of IVD Market in China by End-user 2014
Exhibit 18: Healthcare Expenditure in China 2006 and 2011
Exhibit 19: Healthcare Expenditure in China 2005-2014
Exhibit 20: Number of Medical Institutes in China until 2012
Exhibit 21: Types of IVD Manufacturer in China
Exhibit 22: Key Takeaways: Abbott Diagnostics
Exhibit 23: Key Takeaways: bioMérieux
Exhibit 24: Key Takeaways: Danaher
Exhibit 25: Initiatives by Roche Diagnostics in 2014 to Improve Access to Healthcare
Exhibit 26: Key Takeaways: Roche Diagnostics
Exhibit 27: Abbott Diagnostics: Geographical Presence
Exhibit 28: bioMeriux: Business Segmentation by Revenue 2013
Exhibit 29: bioMeriux: Geographical Segmentation by Revenue 2013
Exhibit 30: Danaher: Business Segmentation
Exhibit 31: Danaher: Business Segmentation 2013
Exhibit 32: Danaher: Revenue by Business Segmentation 2012 and 2013 ($ million)
Exhibit 33: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 34: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 35: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 36: Roche Diagnostics: Geographical Segmentation by Revenue 2014
